These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22134245)
1. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival. Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252 [TBL] [Abstract][Full Text] [Related]
3. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349 [TBL] [Abstract][Full Text] [Related]
4. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186 [TBL] [Abstract][Full Text] [Related]
5. Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer. Eliyatkin N; Aktas S; Diniz G; Ozgur HH; Ekin ZY; Kupelioglu A Pathol Oncol Res; 2018 Jan; 24(1):59-65. PubMed ID: 28236153 [TBL] [Abstract][Full Text] [Related]
6. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Witkiewicz AK; Dasgupta A; Sotgia F; Mercier I; Pestell RG; Sabel M; Kleer CG; Brody JR; Lisanti MP Am J Pathol; 2009 Jun; 174(6):2023-34. PubMed ID: 19411448 [TBL] [Abstract][Full Text] [Related]
7. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. Saeed-Vafa D; Marchion DC; McCarthy SM; Hakam A; Lopez A; Wenham RM; Apte SM; Chen DT; Magliocco AM; Lancaster JM; Reid BM; Permuth JB PLoS One; 2021; 16(11):e0256615. PubMed ID: 34813586 [TBL] [Abstract][Full Text] [Related]
8. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. El-Gendi SM; Mostafa MF; El-Gendi AM Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638 [TBL] [Abstract][Full Text] [Related]
9. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Di Vizio D; Morello M; Sotgia F; Pestell RG; Freeman MR; Lisanti MP Cell Cycle; 2009 Aug; 8(15):2420-4. PubMed ID: 19556867 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients. Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 tumor-promoting role in human melanoma. Felicetti F; Parolini I; Bottero L; Fecchi K; Errico MC; Raggi C; Biffoni M; Spadaro F; Lisanti MP; Sargiacomo M; Carè A Int J Cancer; 2009 Oct; 125(7):1514-22. PubMed ID: 19521982 [TBL] [Abstract][Full Text] [Related]
13. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330 [TBL] [Abstract][Full Text] [Related]
14. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels. Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J Oncology; 2003; 64(4):374-9. PubMed ID: 12759535 [TBL] [Abstract][Full Text] [Related]
15. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas. Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370 [TBL] [Abstract][Full Text] [Related]
17. Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases. Gerstenberger W; Wrage M; Kettunen E; Pantel K; Anttila S; Steurer S; Wikman H Anal Cell Pathol (Amst); 2018; 2018():8651790. PubMed ID: 29850392 [TBL] [Abstract][Full Text] [Related]
18. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer. Shan T; Lu H; Ji H; Li Y; Guo J; Chen X; Wu T PLoS One; 2014; 9(6):e97239. PubMed ID: 24949874 [TBL] [Abstract][Full Text] [Related]
19. Molecular oncogene markers and their significance in cutaneous malignant melanoma. Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628 [TBL] [Abstract][Full Text] [Related]
20. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. He Y; Zhao X; Gao J; Fan L; Yang G; Cho WC; Chen H Int J Mol Sci; 2012 Oct; 13(11):13764-80. PubMed ID: 23203033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]